RESEARCH PAPERS Research papers 목록 2012 [VLP Technology] Effects of downstream processing on structural integrity and immunogenicity in the manufacture of papillomavirus type 16 L1 virus-like particles 2012 [VLP Technology] The production and immunogenicity of human papillomavirus type 58 virus-like particles produced in Saccharomyces cerevisiae 2012 [Therapeutic Agent] Intake of Korean red ginseng extract and saponin enhances the protection conferred by vaccination with inactivated influenza A virus 2011 [VLP Technology] Simple and convenient chromatography-based methods for purifying the pseudovirus of human papillomavirus type 58 2011 [VLP Technology] The composition of the carbon source and the time of cell harvest are critical determinants of the final yield of human papillomavirus type 16 L1 protein produced in Saccharomyces cer… 2011 [Therapeutic Agent] Effect of oral administration of red ginseng on influenza A(H1N1) virus infection, 2010 [VLP Technology] A nontoxic derivative of lipopolysaccharide increases immune responses to Gardasil HPV vaccine in mice 2010 [VLP Technology] One-step chromatographic purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae 2010 [VLP Technology] Optimizing the secondary structure of human papillomavirus type 16 L1 mRNA enhances L1 protein expression in Saccharomyces cerevisiae 2009 [VLP Technology] Serologic response to human papillomavirus type 16 virus-like particles in Korean women with cervical precancerous and cancerous lesions 2009 [VLP Technology] Human papillomavirus 16 and 18 L1 serology in Korean women with high-grade CIN and cervical cancer 2009 [VLP Technology] A method for removing contaminating protein during purification of human papillomavirus type 18 L1 protein from Saccharomyces cerevisiae 2009 [Therapeutic Agent] The Effect of Cell Concentration on Alpha 2,3-sialyltransferase Activity in Attachment Culture of a Human Erythropoietin-producing Chinese Hamster Ovary Cell Line 2008 [VLP Technology] Expression and purification of human papillomavirus 18 L1 virus like particle from Saccharomyces cerevisiae 2008 [VLP Technology] Optimum conditions for production and purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae 2008 [Therapeutic Agent] 12) Antibody-based enzyme-linked lectin assay (ABELLA) for the sialylated recombinant human erythropoietin present in culture supernatant 2007 [VLP Technology] Purification and immunogenicity study of human papillomavirus type 16 L1 protein in Saccharomyces cerevisiae 2007 [Virus Vaccine] Intranasal vaccination with peptides and cholera toxin subunit B adjuvant to enhance mucosal and systemic immunity to respiratory syncythial virus < 1페이지 2페이지 열린3페이지 4페이지 >
